Organic compounds -- part of the class 532-570 series – Organic compounds – Nitriles
Reexamination Certificate
2007-12-25
2007-12-25
Anderson, Rebecca (Department: 1626)
Organic compounds -- part of the class 532-570 series
Organic compounds
Nitriles
C562S450000
Reexamination Certificate
active
10568495
ABSTRACT:
This invention relates to a novel class of compounds, represented by the formula below, wherein the meanings of G, E, E, n, R1, R2, R3et R4are indicated therein, which are cysteine protease inhibitors, including but not limited to, inhibitors of cathepsins K, L, S and B. These compounds are useful for treating diseases in which inhibition of bone resorption is indicated, such as osteoporosis.
REFERENCES:
patent: 2003/0232863 (2003-12-01), Bayly et al.
patent: 2439415 (2002-09-01), None
patent: WO 00/55125 (2000-09-01), None
patent: WO 01/68645 (2001-09-01), None
patent: WO 02069901 (2002-09-01), None
Robichaud, J. et al., Bioorganic & Medicinal Chemistry Letters 14, pp. 4291-4295 (2004), “Rational design of potent and selective NH-linked aryl/heteroaryl cathespin K inhibitors”.
Greenspan, PD et al., J Med. Chem, vol. 44, pp. 4524-4534 (2001), “Identification of dipeptidyl nitriles as potent and selective inhibitors of cathespin B through structure-based drug design”.
Ward, YD et al., J. Med. Chem, vol. 45, pp. 5471-5482 (2002), “Design and synthesis of dipeptide nitriles as reversible and potent cathespin S inhibitors”.
Volonterio, A et al., Organic Letters, vol. 4, No. 13, pp. 1827-1830 (2000), “Synthesis of partially modified retro and tetroinverso [NHCH(CF3)]-peptides”.
Gauthier Jacques Yves
Truong Vouy Linh
Anderson Rebecca
Beeler Nicole M.
Merck Frost Canada & Co.
Muthard David A.
Young Shawquia
LandOfFree
Cathespin cysteine protease inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Cathespin cysteine protease inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cathespin cysteine protease inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3865270